Research analysts at Citigroup Inc. began coverage on shares of Amsurg Corp. (NASDAQ:AMSG) in a report issued on Monday. The brokerage set a “buy” rating and a $79.00 price target on the stock. Citigroup Inc.’s price objective would indicate a potential upside of 21.95% from the company’s previous close.
A number of other equities analysts have also recently issued reports on AMSG. Barclays PLC began coverage on Amsurg Corp. in a report on Wednesday, June 1st. They set an “equal weight” rating and a $85.00 target price for the company. Zacks Investment Research upgraded Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 target price for the company in a report on Monday, July 11th. Goldman Sachs Group Inc. restated a “buy” rating on shares of Amsurg Corp. in a research note on Friday, June 17th. Robert W. Baird restated a “buy” rating on shares of Amsurg Corp. in a research note on Thursday, June 16th. Finally, Cantor Fitzgerald restated a “buy” rating and set a $95.00 price objective on shares of Amsurg Corp. in a research note on Thursday, July 14th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $90.67.
Amsurg Corp. (NASDAQ:AMSG) traded down 1.808% during trading on Monday, hitting $63.609. The stock had a trading volume of 143,578 shares. The company has a market capitalization of $3.42 billion, a price-to-earnings ratio of 18.875 and a beta of 0.65. Amsurg Corp. has a 12-month low of $58.37 and a 12-month high of $87.29. The stock has a 50 day moving average price of $65.74 and a 200 day moving average price of $73.68.
Amsurg Corp. (NASDAQ:AMSG) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, beating the Zacks’ consensus estimate of $1.08 by $0.02. Amsurg Corp. had a net margin of 6.53% and a return on equity of 8.20%. The business earned $758.50 million during the quarter, compared to analysts’ expectations of $769.88 million. During the same quarter in the prior year, the company earned $0.97 EPS. The firm’s quarterly revenue was up 21.5% on a year-over-year basis. Equities research analysts forecast that Amsurg Corp. will post $4.33 earnings per share for the current year.
In related news, insider Robert Jon Coward sold 7,500 shares of the firm’s stock in a transaction dated Thursday, August 18th. The shares were sold at an average price of $64.36, for a total value of $482,700.00. Following the completion of the sale, the insider now directly owns 105,007 shares in the company, valued at approximately $6,758,250.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 2.30% of the stock is currently owned by corporate insiders.
A number of large investors have recently modified their holdings of AMSG. Emerald Acquisition Ltd. purchased a new stake in shares of Amsurg Corp. during the second quarter valued at about $106,000. Smith Asset Management Group LP increased its stake in shares of Amsurg Corp. by 8,500.0% in the second quarter. Smith Asset Management Group LP now owns 1,720 shares of the company’s stock valued at $133,000 after buying an additional 1,700 shares during the period. Invictus RG increased its stake in shares of Amsurg Corp. by 824.3% in the first quarter. Invictus RG now owns 1,904 shares of the company’s stock valued at $142,000 after buying an additional 1,698 shares during the period. Checchi Capital Advisers LLC bought a new stake in shares of Amsurg Corp. during the second quarter valued at about $157,000. Finally, World Asset Management Inc bought a new stake in shares of Amsurg Corp. during the second quarter valued at about $204,000. Institutional investors and hedge funds own 98.42% of the company’s stock.
Amsurg Corp. Company Profile
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Receive News & Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related companies with MarketBeat.com's FREE daily email newsletter.